Language:
English
繁體中文
Help
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Molecular Diagnostics in Cancer Patients
~
Shukla, Kamla Kant.
Molecular Diagnostics in Cancer Patients
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Molecular Diagnostics in Cancer Patients/ edited by Kamla Kant Shukla, Praveen Sharma, Sanjeev Misra.
other author:
Shukla, Kamla Kant.
Description:
VIII, 341 p. 45 illus., 43 illus. in color.online resource. :
Contained By:
Springer Nature eBook
Subject:
Oncology . -
Online resource:
https://doi.org/10.1007/978-981-13-5877-7
ISBN:
9789811358777
Molecular Diagnostics in Cancer Patients
Molecular Diagnostics in Cancer Patients
[electronic resource] /edited by Kamla Kant Shukla, Praveen Sharma, Sanjeev Misra. - 1st ed. 2019. - VIII, 341 p. 45 illus., 43 illus. in color.online resource.
Introduction of molecular diagnostics -- Molecular Diagnostics in Bladder cancer -- Molecular Diagnostics in Lung cancer -- Molecular Diagnostics in Brain cancer -- Molecular Diagnostics in Melanoma -- Molecular Diagnostics in Breast cancer -- Molecular Diagnostics in Non-Hodgkin lymphoma -- Molecular Diagnostics in Cervical cancer -- Molecular Diagnostics in Colorectal cancer -- Molecular Diagnostics in Pancreatic cancer -- Molecular Diagnostics in Oral cancer -- Molecular Diagnostics in Prostate cancer -- Molecular Diagnostics in Kidney cancer -- Molecular Diagnostics in Skin cancer -- Molecular Diagnostics in Leukaemia -- Molecular Diagnostics in Thyroid cancer -- Molecular Diagnostics in Liver cancer -- Molecular Diagnostics in Uterine cancer -- Molecular Diagnostics in Ovarian cancer -- Pharmacogenomics Testing for Medication & Drug Response.
This book aims to bring together a broad variety of examples of the role of pharmacogenomics in current drug development, uncovering dynamic concentration-dependent drug responses on biological systems to understand pharmacodynamics responses in human cancer where genetic lesions serve as tumor markers and provide a basis for cancer diagnosis. The book describes methods and protocols applied in molecular diagnostics. It offers pathologists and researchers providing molecular diagnostic services an array of the most recent and readily accessible reference to compare methods and techniques. Highlights include the molecular diagnosis of genetic aberrations by quantitative polymerase reaction (qPCR), sequence-specific oligonucleotide arrays, next-generation sequencing (NGS), CGH arrays-and methodologies directed at the detection of epigenetic events, high-throughput nucleic acid and protein arrays, direct sequencing and FISH-based methodologies, currently used in the diagnosis of solid tumors. The book also includes an innovative line of treatment in relation to the molecular prognosis, diagnosis and pharmacogenomics in the actual practice of clinical findings at molecular levels. The book covers the applications of numerous genetic testing methodologies; in approximately the chronological order of discovery and high-throughput diagnosis using advanced genomic approaches to identify such genes, in the search for novel drug targets and/or key determinants of drug reactions. It also promotes a wider understanding of molecular diagnostics among physicians, medical students, and scientists in academics, industry and corporate world.
ISBN: 9789811358777
Standard No.: 10.1007/978-981-13-5877-7doiSubjects--Topical Terms:
1253469
Oncology .
LC Class. No.: RC254-282
Dewey Class. No.: 616.994
Molecular Diagnostics in Cancer Patients
LDR
:03810nam a22003855i 4500
001
1004587
003
DE-He213
005
20200704231146.0
007
cr nn 008mamaa
008
210106s2019 si | s |||| 0|eng d
020
$a
9789811358777
$9
978-981-13-5877-7
024
7
$a
10.1007/978-981-13-5877-7
$2
doi
035
$a
978-981-13-5877-7
050
4
$a
RC254-282
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
072
7
$a
MJCL
$2
thema
082
0 4
$a
616.994
$2
23
245
1 0
$a
Molecular Diagnostics in Cancer Patients
$h
[electronic resource] /
$c
edited by Kamla Kant Shukla, Praveen Sharma, Sanjeev Misra.
250
$a
1st ed. 2019.
264
1
$a
Singapore :
$b
Springer Singapore :
$b
Imprint: Springer,
$c
2019.
300
$a
VIII, 341 p. 45 illus., 43 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
505
0
$a
Introduction of molecular diagnostics -- Molecular Diagnostics in Bladder cancer -- Molecular Diagnostics in Lung cancer -- Molecular Diagnostics in Brain cancer -- Molecular Diagnostics in Melanoma -- Molecular Diagnostics in Breast cancer -- Molecular Diagnostics in Non-Hodgkin lymphoma -- Molecular Diagnostics in Cervical cancer -- Molecular Diagnostics in Colorectal cancer -- Molecular Diagnostics in Pancreatic cancer -- Molecular Diagnostics in Oral cancer -- Molecular Diagnostics in Prostate cancer -- Molecular Diagnostics in Kidney cancer -- Molecular Diagnostics in Skin cancer -- Molecular Diagnostics in Leukaemia -- Molecular Diagnostics in Thyroid cancer -- Molecular Diagnostics in Liver cancer -- Molecular Diagnostics in Uterine cancer -- Molecular Diagnostics in Ovarian cancer -- Pharmacogenomics Testing for Medication & Drug Response.
520
$a
This book aims to bring together a broad variety of examples of the role of pharmacogenomics in current drug development, uncovering dynamic concentration-dependent drug responses on biological systems to understand pharmacodynamics responses in human cancer where genetic lesions serve as tumor markers and provide a basis for cancer diagnosis. The book describes methods and protocols applied in molecular diagnostics. It offers pathologists and researchers providing molecular diagnostic services an array of the most recent and readily accessible reference to compare methods and techniques. Highlights include the molecular diagnosis of genetic aberrations by quantitative polymerase reaction (qPCR), sequence-specific oligonucleotide arrays, next-generation sequencing (NGS), CGH arrays-and methodologies directed at the detection of epigenetic events, high-throughput nucleic acid and protein arrays, direct sequencing and FISH-based methodologies, currently used in the diagnosis of solid tumors. The book also includes an innovative line of treatment in relation to the molecular prognosis, diagnosis and pharmacogenomics in the actual practice of clinical findings at molecular levels. The book covers the applications of numerous genetic testing methodologies; in approximately the chronological order of discovery and high-throughput diagnosis using advanced genomic approaches to identify such genes, in the search for novel drug targets and/or key determinants of drug reactions. It also promotes a wider understanding of molecular diagnostics among physicians, medical students, and scientists in academics, industry and corporate world.
650
0
$a
Oncology .
$3
1253469
650
1 4
$a
Oncology.
$3
593951
700
1
$a
Shukla, Kamla Kant.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1298093
700
1
$a
Sharma, Praveen.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1298094
700
1
$a
Misra, Sanjeev.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1298095
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9789811358760
776
0 8
$i
Printed edition:
$z
9789811358784
856
4 0
$u
https://doi.org/10.1007/978-981-13-5877-7
912
$a
ZDB-2-SME
912
$a
ZDB-2-SXM
950
$a
Medicine (SpringerNature-11650)
950
$a
Medicine (R0) (SpringerNature-43714)
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login